AI & ChatGPT searches , social queriess for NUSINERSEN
Search references for NUSINERSEN. Phrases containing NUSINERSEN
See searches and references containing NUSINERSEN!
Search references for NUSINERSEN. Phrases containing NUSINERSEN
See searches and references containing NUSINERSEN!NUSINERSEN
Medication used for spinal muscular atrophy
Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became
Nusinersen
Rare congenital neuromuscular disorder
forms. Medications that target the genetic cause of the disease include nusinersen, risdiplam, and the gene therapy medication onasemnogene abeparvovec.
Spinal_muscular_atrophy
Biotechnology company
of pharmaceuticals under development. In December 2016, Ionis's drug nusinersen (Spinraza) was approved by the FDA. It had been discovered in a collaboration
Ionis_Pharmaceuticals
American pharmaceutical company
treatment of multiple sclerosis (collectively 45% of 2024 revenues); nusinersen (Spinraza) for the treatment of spinal muscular atrophy (16.2% of 2024
Biogen
Drug injected into the spinal canal
RNA with high selectivity. Treatment of spinal muscular atrophy with Nusinersen is an example. Treatment of chronic spinal injuries via the administration
Intrathecal_administration
emerging treatments. In a collaborative study, Topaloğlu demonstrated that nusinersen improves motor function and increases survival likelihood in infants with
Haluk_Topaloğlu
Chemical compound
increase in the concentration of the functional SMN protein in vivo. Nusinersen, the first drug approved to treat SMA, an anti-sense oligonucleotide targeting
Risdiplam
Form of treatment for genetic disorders and other illnesses
oligonucleotide later named nusinersen was developed by Ionis Pharmaceuticals under a licensing agreement with Biogen. In December 2016, nusinersen received regulatory
Antisense_therapy
Book
stage 4 gallbladder cancer. Later, this cancer spreads to her brain! Nusinersen is a medication used in treating spinal muscular atrophy (SMA). Jesse
The_Gene:_An_Intimate_History
American nonprofit organization
Laboratory in Laurel Hollow, New York for the early-stage development of nusinersen. Nusinersen became FDA approved in 2016 as the first treatment for spinal muscular
Muscular Dystrophy Association
Muscular_Dystrophy_Association
Private, non-profit research institution in US
and National Academy of Sciences member. Adrian R. Krainer, developed nusinersen to treat spinal muscular atrophy (SMA), winner of the Breakthrough Prize
Cold_Spring_Harbor_Laboratory
Pharmaceutical drug classification
M09AX04 Drisapersen M09AX05 Aceneuramic acid M09AX06 Eteplirsen M09AX07 Nusinersen M09AX08 Golodirsen M09AX09 Onasemnogene abeparvovec M09AX10 Risdiplam
ATC_code_M09
American pharmacologist
antisense technology for the treatment of neurological diseases, including nusinersen, a treatment for Spinal Muscular Atrophy, and several antisense drugs
C._Frank_Bennett
Study of role of genetics in the nervous system
Similarly, antisense oligonucleotide (ASO) therapies like tofersen and nusinersen work by modulating RNA splicing or reducing toxic protein expression in
Neurogenetics
Chemical compound
regulatory challenges and competition from a potentially more effective drug nusinersen, Roche halted further development of olesoxime. Martin LJ (August 2010)
Olesoxime
drisapersen, eplontersen, evazarsen, gataparsen, inotersen, IONIS-GCCRRx, nusinersen, oblimersen, olezarsen, pelacarsen, sefaxersen, tofersen, and volanesorsen
Phosphorothioate_nucleic_acid
N1 (ISS-N1) target that led to the first FDA-approved drug (Spinraza/Nusinersen) for the treatment of spinal muscular atrophy (SMA). He is the recipient
Ravindra_N._Singh
Nufymco Nulytely Numax Numorphan nupafant (INN) Nuprin Nurofen Nuromax nusinersen (INN) Nutracort Nutrestore Nutrilipid Nutropin Nutropin AQ Nuvaring Nuvaxovid
List_of_drugs:_Nj–Nz
Use of non-coding RNA to treat disease
to target mRNA at different stages of maturation. One such example is Nusinersen (Spinaraza), it functions as an ASO and targets pre-mRNA before splicing
NcRNA_therapy
Scientific research area
pathogenic ApoB mRNA (US approval granted 2013). Spinraza (branded as Nusinersen) for the treatment of Spinal Muscular Atrophy (SMA), administered by intrathecal
Intracellular_delivery
NUSINERSEN
NUSINERSEN
NUSINERSEN
NUSINERSEN
Girl/Female
American, Australian, British, Chinese, Christian, English
Twilight; Form of Twyla; Thread
Male
Chinese
little birth.
Boy/Male
Muslim
Brave
Boy/Male
Arabic, Muslim
Sufficient; Enough
Boy/Male
Indian
Peace
Boy/Male
Arabic, Muslim
Meteor of the Religion Islam
Boy/Male
American, Australian, British, Chinese, Christian, English
Coal Town; Town of Colt-breeding; Dark Settlement
Boy/Male
Tamil
Biblical
Jehovah hears;
Boy/Male
Tamil
Ved Aryan | வேத ஆரà¯à®¯à®¨Â
Sacred knowledge
NUSINERSEN
NUSINERSEN
NUSINERSEN
NUSINERSEN
NUSINERSEN